This education module explores the pharmacological and non-pharamacological management of type 2 diabetes and its comorbities, with a focus on management options in patients with renal impairment.
This education discusses the common causes of vision loss, the presenting features, diagnostic assessments and management. Indications for referral and the contents of referral letters to the optometrist/ophthalmologist are detailed.
A critical review and appraisal of the different treatment options for patients with chronic obstructive pulmonary disease (COPD), with a focus on tailoring the treatment to the different needs of patients.
Hereditary mutations of the tumour suppressor genes BRCA1 and BRCA2 can lead to an elevated risk of breast cancer. This education explores how to identify affected patients with a family history of cancer, and provides an overview of how Family Cancer Clinics can assist these patients through genetic testing and risk management.
This ALM will guide GPs through the epidemiology of skin cancers in Australia, skin cancer prevention, balanced approach to UV and vitamin D awareness and the diagnosis and management of melanoma and the most common non-melanoma skin cancers.
This education discusses melanoma in detail, including the Epidemiology, clinical diagnosis, dermoscopy and imaging, management and review of the pathology report with follow up.
This education describes the assessment and management of basal and squamous cell carcinoma. Each condition is described in terms of its epidemiology, risk factors and clinical features. Numerous naked eye and dermoscopic images illustrate the non melanoma skin conditions.
This education covers the incidence of sun related skin cancers in Australia and discusses the link between UV exposure and skin cancer. Safe UV exposure is explored. Methods of full skin examination are described and the various biopsy techniques are detailed.
This module uses several case studies as a platform to discuss topics such as identifying patients at risk of CKD, diabetic kidney disease and heavy proteinuria.